The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy vo... by Meriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu, Mayra Ponce, Caroline Truntzer, Romain Boidot, Clément Le Bescop, Thomas Loppinet, Tanguy Corbel, Céline Féger, Karine Bertrand, Arielle Elkrief, Morten Isaksen, Fabien Vitry, Frédérique Sablier-Gallis, Antoine Andremont, Lloyd Bod, François Ghiringhelli, Jean de Gunzburg, Bertrand Routy

Get full text

561 Targeting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy by Nir Hacohen, Soldano Ferrone, Keith Flaherty, Tatyana Sharova, Genevieve M Boland, Robert T Manguso, Payal Tiwari, Debattama R Sen, Arnav Mehta, William Michaud, Or-Yam Revach, Angelina Cicerchia, Moshe Sade-Feldman, Seth Anderson, Boryana Petrova, Ofir Shorer, Lloyd Bod, Giulia Cattaneo, Hongyan Xie, Martin Rasmussen, Jacy Fang, Keren Yizhak, Naama Kanarek, Russell Jenkins